Table 2 Summary of baseline characteristics in patient populations
Author | Age | Male Gender (%) | NYHA class 3–4 (%) | Hypertension (%) | Coronary Disease (%) | Cerebro-vascular events (%) | Atrial fibrillation (%) | LV impairment (%) | LVEF (%) |
|---|---|---|---|---|---|---|---|---|---|
Grossi et al. [10] | 65* | 56.1 | NI | NI | NI | NI | NI | NI | NI |
Nasso et al. [11] | 54.1 ± 10.5 | 56.8 | 26.8 | NI | NI | NI | NI | 26.8 | NI |
Nishi et al. [12] | 55.5 ± 12.6 | 59.8 | 11.3 | 41.6 | NI | 2.8 | NI | 11 | NI |
Downs et al. [13] | 58.1 ± 13.5 | 60.6 | 19.4 | 56.8 | NI | NI | NI | NI | 57.9 ± 9.6 |
Hawkins et al. [14] | 61.6 ± 13.8 | 57.4 | NI | 60.1 | 14.1 | 10.1 | 39.9 | NI | 60 |
Wang Q et al. [15] | 51 ± 12 | 51.5 | 26.9 | 22.4 | NI | 2.2 | 39.5 | NI | 55.9 ± 12 |
Grant et al. [16] | 62.8 ± 12.6 | 66.4 | 47.6 | 45.6 | 5.9 | 2.7 | 33.6 | 17.5 | NI |
Liu et al. [17] | 50.7 ± 11.5 | 34.6 | 26.9 | 6.9 | 2.2 | 6.7 | 49.2 | NI | 62.8 ± 7.9 |
Paparella et al. [18] | 66.5 ± 12 | 48.9 | NI | 62 | 6.5 | 1 | 29.2 | 26.6 | NI |
Cetinkaya et al. [19] | 64.1 ± 12.7 | 54.7 | 84.8 | 49.5 | 7.7 | 5.2 | 33.4 | NI | 57.5* |
Pojar et al. [20] | 65.1 ± 10.1 | 41.5 | 43.3 | 73 | NI | 8.1 | 44.3 | NI | 58.4 ± 10.7 |
Olsthoorn et al. [21] | 63.6 ± 12 | 57 | NI | NI | NI | NI | NI | 14.6 | NI |
Mihaljevic et al. [22] | 61 ± 11 | 75 | 20 | 46 | NI | 1.8 | 7 | NI | NI |
Suri et al. [23] | 55.3 ± 12.6 | 78.4 | 10 | 32.1 | 1.6 | 0.5 | 4.7 | NI | 65.3 ± 6.2 |
Iyigun et al. [24] | 49.9 ± 13.7 | 32.2 | NI | NI | NI | NI | NI | NI | NI |
Hawkins et al. [25] | 61* | 58.1 | NI | 63.2 | 14.9 | 6.2 | 10.8 | NI | 60* |
Wang A et al. [26] | 71 ± 5 | 61 | 44.9 | 68.2 | 7.4 | 3.4 | 14.4 | NI | 59 ± 8 |
Coyan et al. [27] | 62* | 56 | 32 | 57 | NI | 10 | 26 | NI | 59* |